GangaGen´s lead product is, StaphTAME, a proprietary recombinant protein, P128, for the prevention or treatment of Staphylococcal infections, including infection with methicillin-resistant Staphylococcus aureus (MRSA).
Nasal decolonization of S.aureus – first in human study of P128 (StaphTAME)
In addition to treating bacterial diseases, bacteriophage preparations can be used as prophylactics to control or prevent epidemics.
Gram negative infections
Phages that kill without release of bacterial toxic contents